TransMedics TMDX Cash Flow Statement (2018-2026)

NASDAQ TMDX
$74.75 +3.15 (+4.40%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

TransMedics Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

TransMedics reported cash from operations of $17.31M and free cash flow of $10.22M for the quarter ended Jun 2026, down 81.1% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-12.96M-12.67M-10.56M-11.52M-7.43M-6.72M-2.64M-1.00M-25.42M4.03M12.20M12.19M4.22M6.86M25.68M34.91M24.32M105.38M7.32M14.68M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.31M0.28M0.23M0.14M0.01M
Depreciation & Amortization (CF)Dep. & Amort.
0.46M0.47M0.51M0.80M0.89M1.29M1.30M1.38M1.89M3.61M4.30M4.60M5.18M5.68M6.14M6.73M6.85M7.47M11.86M10.24M
Share-based CompensationStock Comp.
1.97M1.99M2.31M2.32M2.70M2.99M3.92M4.96M5.19M5.72M6.87M7.64M7.94M10.77M8.96M9.37M9.14M9.40M9.95M8.61M
Deferred Taxes
-0.12M1.07M3.80M
Gains from Sales and DivestituresGains Divest
-0.08M
Other non-cash itemsOther Non-Cash
0.41M1.31M0.53M1.14M1.49M-0.26M0.16M0.71M27.21M0.62M1.29M1.11M0.75M2.19M0.69M0.41M1.34M1.15M5.69M5.42M
Change in Working Capital
Change in ReceivablesChange Receivables
-2.09M1.81M5.80M1.33M9.16M5.39M10.96M8.90M11.14M2.82M18.41M-0.76M8.82M7.84M44.13M-37.52M-24.15M3.58M6.52M13.43M
Change in InventoryChange Inventory
2.07M0.93M2.93M1.23M1.94M1.93M3.62M7.35M10.05M7.06M5.61M2.32M4.56M-4.14M-2.00M-3.71M6.90M6.53M3.90M6.35M
Change in Account PayablesChange Payables
0.29M3.86M-4.01M2.40M-1.92M0.26M1.03M2.65M2.87M0.42M-2.04M3.82M-0.04M-3.14M0.78M-1.19M2.46M-2.06M1.13M1.60M
Change in Accured ExpensesChange Accured Exp.
0.37M2.52M0.00M-0.24M0.23M3.45M3.45M0.74M5.06M4.99M-0.05M0.68M4.98M2.32M-4.64M2.23M13.14M6.97M-3.11M-2.23M
Change in Other Operating AssetsOther Assets Change
0.06M1.84M-0.09M1.24M-1.06M-2.62M0.94M-1.40M2.69M-0.07M1.60M1.64M2.93M0.25M-1.93M0.85M5.91M-1.05M-1.81M4.44M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.15M0.17M1.24M-0.32M-0.33M-0.34M-0.35M-0.39M0.41M-1.16M-0.39M-1.12M0.11M-1.07M-0.33M-1.24M1.00M-1.18M-0.77M-0.60M
Other Working Capital ChangesOther WC Changes
-0.21M-1.66M1.33M-1.56M0.73M2.28M-1.29M1.01M-2.28M-1.09M-1.99M-2.76M-2.82M-1.31M1.59M-2.09M-4.91M-0.13M1.04M-5.03M
Cash from OperationsCash from Ops.
-9.35M-6.65M-18.41M-9.09M-14.28M-4.04M-8.66M-5.80M-6.87M8.30M-3.44M25.72M6.86M19.66M-2.86M91.61M69.57M34.51M24.53M17.31M
Investing Activities
Capital ExpendituresCapex
0.07M3.18M1.95M4.26M2.93M2.76M0.93M1.38M107.72M41.82M44.17M23.76M48.20M13.61M27.04M9.08M7.62M15.51M36.66M7.09M
Change in Property, Plant and EquipmentChange in PP&E
-0.07M-3.18M-1.95M-4.26M-2.93M-2.76M-0.93M-1.38M-107.72M-41.82M-44.17M-23.76M-48.20M-13.61M-27.04M-9.08M-7.62M-15.51M-36.66M-7.09M
Purchase of InvestmentsInvestments Purchased
21.23M5.33M2.03M7.48M0.99M
Sale and Maturity of InvestmentsInvestments Sold
27.50M18.50M14.50M33.75M28.67M
Cash from Investing ActivitiesCash from Investing
6.20M9.99M10.51M22.02M24.75M-2.76M-0.93M-1.38M-149.83M-41.82M-44.17M-23.76M-47.76M-13.61M-27.04M-9.08M-7.62M-15.51M-36.66M-7.09M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
0.55M0.05M0.20M0.44M1.75M3.23M3.96M0.71M1.52M0.92M3.19M10.64M7.86M1.19M3.03M7.09M3.78M3.10M3.90M1.01M
Net Shares Issued and RepurchasedNet Shares Issued
0.55M0.05M0.20M0.44M1.75M3.23M3.96M0.71M1.52M0.92M3.19M10.64M7.86M1.19M3.03M7.09M3.78M3.10M3.90M1.01M
Net Equity Issued and RepurchasedNet Equity Issued
0.55M0.05M0.20M0.44M1.75M3.23M3.96M0.71M1.52M0.92M3.19M10.64M7.86M1.19M3.03M7.09M3.78M3.10M3.90M1.01M
Other financing activitiesOther financing
-0.14M-0.14M-0.04M
Cash from Financing ActivitiesCash from Financing
0.55M0.05M0.41M0.24M164.22M3.07M3.96M394.01M1.52M0.92M3.19M10.64M7.86M1.19M3.03M7.09M3.64M3.10M3.76M0.97M
Additional items
Exchange Rate EffectFX Effect
-0.22M-0.30M-0.20M-0.67M-0.61M0.45M0.07M0.01M-0.18M0.29M-0.17M-0.06M0.39M-0.69M0.36M0.81M0.01M0.09M-0.33M-0.25M
Change in Cash
-2.82M3.09M-7.68M12.49M174.08M-3.28M-5.56M386.84M-155.35M-32.30M-44.60M12.53M-32.66M6.56M-26.51M90.43M65.60M22.19M-8.69M10.94M
Ending Cash Balance
23.00M26.08M18.40M30.89M204.96M201.68M196.13M582.96M427.61M395.31M350.72M363.25M330.59M337.15M310.64M401.08M466.67M488.87M480.18M491.11M
Free Cash FlowFCF
-9.42M-9.83M-20.36M-13.35M-17.21M-6.80M-9.59M-7.18M-114.59M-33.51M-47.61M1.96M-41.35M6.06M-29.89M82.53M61.95M19.00M-12.12M10.22M
Net Cash FlowNCF
-2.60M3.39M-7.49M13.16M174.69M-3.73M-5.63M386.83M-155.17M-32.59M-44.42M12.60M-33.04M7.24M-26.87M89.62M65.59M22.10M-8.36M11.19M

TransMedics Cash Flow Statement API

Pull TransMedics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TMDX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY